Tetra Bio-Pharma Announces the Completion of its Phase 1 Safety Report to Health Canada and Launches the Preparation of a Phase ...
OTTAWA, ONTARIO--(Marketwired - Jun 7, 2017) - Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (CSE:TBP)(CSE:TBP.CN)(CNSX:TBP)(OTCQB:TBPMF), and PhytoPain Pharma (PPP), a subsidiary of Tetra Bio-Pharma, is pleased to announce that it …